Sandra Smink

Sandra Smink is an active researcher specializing in pancreatic islet research, diabetes treatment, and regenerative medicine. Her work focuses on tissue engineering solutions for Type 1 Diabetes, including bioartificial pancreatic constructs and immunological aspects of islet transplantation. She has contributed to understanding maternal gut bacteria's role in fetal immune development and explored biomarkers in preeclampsia pathophysiology.

Smink has published 41 research outputs since 2022, with recent work appearing in Journal of Physiology, Cells, and Seminars in Immunopathology. She serves as Guest Editor for Polymers and holds leadership roles in the European Association for the Study of Diabetes (EASD) Academy since 2022.

Her research interests align with UN Sustainable Development Goals addressing health and well-being. In 2018, she received the Prof. Dr. J. Terpstra Young Investigators award for high-quality diabetes research. Smink has engaged in public outreach through EASD TV interviews and presentations like 'Engineering a highly vascularized islet transplantation site' at academic conferences.